Sohm, Inc. (SHMN)
Sohm, Inc. is a healthcare company focused on generic and private label pharmaceuticals. Through its operations, the company develops, manufactures, markets, and distributes products in the United States, including analgesics, antibiotics, anti-cold medicines, and anti-inflammatory drugs. Its portfolio also includes over-the-counter products, cosmeceuticals, and nutraceuticals, and it exports products as part of its business. In addition, Sohm has a collaboration agreement with Coastar Therapeutics aimed at advancing genome editing using red blood cell membrane derived carriers and genome editing technology. Founded in 2005, the company is based in Corona, California. The listed security is common stock on OTC Markets under the symbol SHMN.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-SHMN
|
—
|
—
|
—
|
—
|
—
|
—
|
Great
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
3.185 M
|
—
|
—
|
—
|
—
|
—
|
—
|